Zoledronic acid sequential therapy could avoid disadvantages due to the discontinuation of less than 3-year denosumab treatment

INTRODUCTION: Rapid descent in bone mineral density (BMD) and ascent in bone turnover marker (BTM) occur within the short period following denosumab (Dmab) discontinuation. In addition, the incidence of vertebral fracture also rises within the short period. The purpose of this study is to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Hideomi, Okimoto, Nobukazu, Yoshioka, Toru, Akahoshi, Shojiro, Fuse, Yoshifumi, Ogawa, Takayuki, Okazaki, Yuichi, Katae, Yuji, Tsukamoto, Manabu, Yamanaka, Yoshiaki, Kawasaki, Makoto, Sakai, Akinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354744/
https://www.ncbi.nlm.nih.gov/pubmed/32656645
http://dx.doi.org/10.1007/s00774-020-01126-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354744/
https://www.ncbi.nlm.nih.gov/pubmed/32656645
http://dx.doi.org/10.1007/s00774-020-01126-w

Ejemplares similares